NFKB1 and central nervous system cancer: Among them, berberine (BBR) consistently inhibits NF-κB signaling, reduces pro-inflammatory cytokines, and triggers apoptosis, with glioma-cell data showing growth and migration suppression through TGF-β/SMAD and mitochondrial pathways [56].